Stock Research for ATNM


Featured Broker: Ally Invest

Get the due diligence for another stock.


ATNM Stock Chart & Research Data

The ATNM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATNM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ATNM Due diligence Resources & Stock Charts

The ATNM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ATNM Detailed Price Forecast - CNN Money CNN View ATNM Detailed Summary - Google Finance
Yahoo View ATNM Detailed Summary - Yahoo! Finance Zacks View ATNM Stock Research & Analysis -

Stock Analysis

TradeIdeas View ATNM Trends & Analysis - Trade-Ideas Barrons View ATNM Major Holders - Barrons
NASDAQ View ATNM Call Transcripts - NASDAQ Seeking View ATNM Breaking News & Analysis - Seeking Alpha
Spotlight View ATNM Annual Report - OTC Report View ATNM OTC Short Report -
TradeKing View ATNM Fundamentals - TradeKing Charts View ATNM SEC Filings - Bar Chart
WSJ View Historical Prices for ATNM - The WSJ Morningstar View Performance/Total Return for ATNM - Morningstar
MarketWatch View the Analyst Estimates for ATNM - MarketWatch CNBC View the Earnings History for ATNM - CNBC
StockMarketWatch View the ATNM Earnings - StockMarketWatch MacroAxis View ATNM Buy or Sell Recommendations - MacroAxis
Bullish View the ATNM Bullish Patterns - American Bulls Short Pains View ATNM Short Pain Metrics -

Social Media Mentions

StockTwits View ATNM Stock Mentions - StockTwits PennyStocks View ATNM Stock Mentions - PennyStockTweets
Twitter View ATNM Stock Mentions - Twitter Invest Hub View ATNM Investment Forum News - Investor Hub
Yahoo View ATNM Stock Mentions - Yahoo! Message Board Seeking Alpha View ATNM Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ATNM - Insider Cow View Insider Transactions for ATNM - Insider Cow
CNBC View ATNM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ATNM - OTC Markets
Yahoo View Insider Transactions for ATNM - Yahoo! Finance NASDAQ View Institutional Holdings for ATNM - NASDAQ

Stock Charts

FinViz View ATNM Stock Insight & Charts - StockCharts View ATNM Investment Charts -
BarChart View ATNM Stock Overview & Charts - BarChart Trading View View ATNM User Generated Charts - Trading View

Latest Financial News for ATNM

Actinium Pharmaceuticals to Participate in the Oppenheimer & Co. Fall Summit Focused on Specialty Pharma and Rare Disease
Posted on Thursday September 20, 2018

NEW YORK , Sept. 20, 2018 /PRNewswire/ --  Actinium Pharmaceuticals, Inc.   (NYSE AMERICAN: ATNM) today announced that the Company will participate in the Oppenheimer & Co. Fall Summit Focused on Specialty ...

Should You Worry About The Actinium Pharmaceuticals Inc’s (NYSEMKT:ATNM) Shareholder Register?
Posted on Tuesday September 18, 2018

A look at the shareholders of Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely,Read More...

Actinium Pharmaceuticals to Host Webinar Showcasing New Pipeline Initiative Focused on the CAR-T Space
Posted on Tuesday September 18, 2018

NEW YORK, Sept. 18, 2018 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE American: ATNM) ("Actinium" or "the Company"), announced today that it will unveil a new clinical initiative that expands the Company's pipeline into the CAR-T space. CAR-T is a type of cellular therapy that genetically alters a patient's own T cells to target and kill their cancer cells.

Actinium Appoints Robert N. Daly, Ph.D. to Newly Created Role of Vice President, Head of Clinical Operations
Posted on Thursday September 06, 2018

NEW YORK, Sept. 6, 2018 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) today announced the appointment of Robert N. Daly, M.S., Ph.D., to the position of Vice President, Head of Clinical Operations, effective immediately. In this role, Dr. Daly will oversee all clinical operations, with a focus on executing Actinium's progressing pivotal Phase 3 trial for Iomab-B as a targeted conditioning agent, driving forward the Company's growing CD33 program including its advancement in targeted conditioning, as well as future clinical trial expansion for the entire pipeline.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.